OpenAlex
PricingAboutJobs
Log inGet started
Work

A Comparison of the Steady-State Pharmacokinetic and Pharmacodynamic Profiles of 100 and 200 U/mL Formulations of Ultra-Long-Acting Insulin Degludec

HTML

Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Clinical Drug Investigation
DOI: 10.1007/s40261-013-0096-7
Authors: Stefan Korsatko, Sigrid Deller, Gerd Koehler, Julia K. Mader, Katharina Neubauer, Charlotte L. Adrian, Henrik Thomsen, Hanne Haahr, Thomas R. Pieber
Institutions: University of Graz, Medical University of Graz, Novo Nordisk (Denmark)
Language: English

Topic: Diabetes Management and Research
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: insulin degludec, ultra-long-acting insulin, insulin levels, bioequivalence, type 1 diabetes, basal insulin, glucose infusion rate, glucose-lowering effect, insulin aspart
SDG: Good health and well-being

Open Access status: closed

Funder: Novo Nordisk
OpenAlex ID: W2081755201
FWCI: 5.008
Cites: 20
Cited by: 91
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security